Tuesday, October 20

Healthcare

Terns stock jumps as weight loss drug succeeds in early trial

09/10/20241 Min Read

drug early jumps loss stock succeeds Terns trial weight

Previous ArticleCassava Sciences’ Richard Barry to take helm as permanent CEO

Next Article Summit stock soars as lung cancer drug beats Merck’s Keytruda in late-stage trial